Group Crit Schedule 2017/2018: Difference between revisions

From XPUB & Lens-Based wiki
No edit summary
mNo edit summary
 
(5 intermediate revisions by 4 users not shown)
Line 45: Line 45:


SESSION 6:  24 APRIL
SESSION 6:  24 APRIL
<br/>1.   
<br/>1.  Lotte
<br/>2.   
<br/>2.  Qian
<br/>3.   
<br/>3.   


Line 55: Line 55:


SESSION 8:  22 May
SESSION 8:  22 May
<br/>1.   
<br/>1.  Ryan
<br/>2.   
<br/>2.   
<br/>3.
<br/>3.
Line 61: Line 61:
SESSION 9:  05 June
SESSION 9:  05 June
<br/>1.  Sal
<br/>1.  Sal
<br/>2.
<br/>2. Zhibin
<br/>3.
 
SESSION 10:  19 June
<br/>1. 
<br/>2. 
<br/>3.
<br/>3.

Latest revision as of 13:20, 4 June 2018

Group Crit

Each of you has the opportunity to present your current research and plans future research in 20 minutes -- and this is followed by an approx 25 - 35 minutes discussion with your peers.

Simon and/or Barend will chair the group but will not participate in the discussion: this session is designed as a chance to discuss your work with your fellow students: so please come prepared to ask questions of others as well as make your own presentation.

The core question to consider is: how are you developing your practice into something new? Ideally, presentations should cover:

CONTEXT - what work of others would you consider as creating a useful context for your own work?

STRATEGIES for development

PURPOSE and underlying ambitions

CURRENT experiments and works.


it will be scheduled every other Tuesday 14.30 - 17.30 and so each week we will view three people's work. After the first round of everybody having presented, we will have a second meeting to discuss format and adjustments we wish to make before the next round.


SESSION 1: 09 JAN
1. Fabian
2. Irma
3. Zhibin

SESSION 2: 23 JAN
1. Rosella
2. Shinyoung
3. Mike

SESSION 3: 6 FEB
1. Sigrun
2. Ryan
3.

SESSION 4: 20 FEB
1. Dorothy
2. Salvador
3. Ana B

SESSION 5: 13 March
1. Catalina
2. Anna
3. Mike

SESSION 6: 24 APRIL
1. Lotte
2. Qian
3.

SESSION 7: 08 May
1.
2.
3.

SESSION 8: 22 May
1. Ryan
2.
3.

SESSION 9: 05 June
1. Sal
2. Zhibin
3.